actelion ltd-reg (ATLN:SIX Swiss Ex)
Armin M. Kessler
Former Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee, Actelion Ltd.
|Age||Total Calculated Compensation||This person is connected to 37 board members in 4 different organizations across 8 different industries.|
See Board Relationships
Mr. Armin M. Kessler served as the Chief Operating Officer of Hoffman-La Roche from 1990 to 1995. Mr. Kessler is an experienced global pharmaceutical and biotech industry Executive. From 1983 until he retired in 1995, he held several senior positions at Hoffman-La Roche, including Head of the Pharmaceutical Division, Head of the Diagnostic Division with worldwide responsibility for pharmaceuticals, diagnostics, vitamins and chemicals and Managing Director of Roche U.K. ...
Gewerberstrasse 16Phone: 41 61 565 65 65
Allschwil, Basel-Landschaft 4123
Fax: 41 61 565 65 00
Board Members Memberships*
Former Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee
Independent Director and Member of Compensation Committee
Former Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Former Lead Independent Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Former Director, Chairman of Nominating & Corporate Governance Committee, Member of Compensation Committee and Member of Audit Committee
Seton Hall University
University of Cape Town
Honorary Doctorate 1993
University of Pretoria
University of Pretoria
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|James Patrick Mackin||Chief Executive Officer, President and Director|
|Peter J. Arduini||Chief Executive Officer, President, Director and Member of Special Award Committee|
Integra LifeSciences Holdings Corporation
|Timothy M. Ring||Chairman, Chief Executive Officer and Chairman of Executive Committee|
CR Bard Inc.
|Albert David Friesen Ph.D.||Founder, Chairman and Chief Executive Officer|
|Rick E. Winningham||Chairman, Chief Executive Officer and Member of Science & Technology Committee|
Theravance Biopharma, Inc.
|$1.4M||Compensation as of Fiscal Year --.|